Advances in Radiopharmaceuticals: Enhancing Targeted Delivery, Disease Diagnosis, and Therapeutic Applications
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Clinical Pharmaceutics".
Deadline for manuscript submissions: 31 December 2025 | Viewed by 167
Special Issue Editors
2. State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100050, China
Interests: radiopharmaceuticals; peptide; PET imaging; radiotheranostics; cancer management
Special Issues, Collections and Topics in MDPI journals
Interests: cancer research; radiopharmaceuticals; cell culture; nanoparticles
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Radiopharmaceuticals are designed to target either tumor- or non-tumor-associated tissues, delivering single or paired radioactive atoms based on specific diagnostic or therapeutic needs. The selection of ligands—such as proteins, peptides, antibodies, nanoparticles, and drugs—depends on the chosen radioactive atom and the intended target tissue, allowing for the targeting of a wide range of tissues. Additionally, the diversity of radioactive atoms, characterized by variations in energy type, density, and half-life, plays a crucial role in effectively targeting tissues while facilitating the diagnosis and treatment of numerous diseases. Although the primary application of radiopharmaceuticals is in the diagnosis and treatment of cancer, their potential extends to the management of other medical conditions as well.
This Special Issue aims to underscore the capabilities of ligands and radioactive atoms in diagnosing and treating diseases through innovative approaches or by integrating existing methods with synergistic elements. We encourage authors to contribute articles that explore the pathways of radiopharmaceuticals in disease diagnosis and therapy for this Special Issue.
Dr. Kuan Hu
Dr. Volkan Tekin
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- radiopharmaceuticals
- radiotherapy
- diagnosis
- therapy
- targeting delivery
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
